Document text
Principal Investigator: TERRY L. SHEPPARD
Organization: KEYSTONE SYMPOSIA
Fiscal Year: 2023
Award: $7,500
Funding agency: National Institute of Allergy and Infectious Diseases
ABSTRACT
Support is requested for a Keystone Symposia conference entitled Vaccinology During and After COVID-19,
organized by Drs. Bali Pulendran, Robert Seder and Gagandeep Kang. The conference will be held in Atlanta,
Georgia from September 17-21, 2023.
Since its emergence, SARS-CoV-2 has radically transformed practically every dimension of our lives and
fueled an urgent global imperative to develop safe and effective vaccines. The stunning pace at which COVID-
19 vaccines have been developed is unprecedented in the history of vaccinology and has been catalyzed by
the rapid harnessing of innovative new technologies (e.g., mRNA vaccines) and major public and private
investments. The COVID-19 pandemic offered a unique vantage point from which to survey vaccinology as it
was for the past two centuries, since Edward Jenner and the eradication of smallpox, to how it is now, during
the time of COVID-19, and to consider what it could be in the post-COVID era. Equally important has been the
world’s focus on the economics, politics and ethics of how to ensure global equitable access to COVID-19
vaccines. This virus has certainly shone a spotlight on the field of vaccinology as it is, at the focal point of
immunology, microbiology, public health, clinical medicine, economics, sociology, ethics and international
diplomacy. Thus, some talks will also be focused on these broader issues surrounding the field. It is anticipated
that this conference will stimulate debate that helps enhance pandemic preparedness by redefining the way we
conceive of, make, test, license and distribute vaccines globally. Overall, this conference is designed to bring
together an interdisciplinary team of experts to discuss the lessons learnt from the COVID-19 pandemic, with a
particular focus on the immunology of vaccination.
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><2019-nCoV vaccine><Affect><Antibody Response><B blood cells><B cell><B cells><B-Cells><B-Lymphocytes><B-cell><COVID crisis><COVID epidemic><COVID pandemic><COVID-19><COVID-19 affected><COVID-19 consequence><COVID-19 crisis><COVID-19 effect><COVID-19 epidemic><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 impact><COVID-19 impacted><COVID-19 pandemic><COVID-19 public health crisis><COVID-19 vaccine><COVID-19 virus><COVID19><COVID19 crisis><COVID19 epidemic><COVID19 global health crisis><COVID19 global pandemic><COVID19 health crisis><COVID19 pandemic><COVID19 public health crisis><COVID19 vaccine><COVID19 virus><CV-19><CV19><Clinical Medical Sciences><Clinical Medicine><CoV-2><CoV2><Collaborations><Communicable Diseases><Development><Dimensions><Drugs><Economics><Educational workshop><Ensure><Equity><Ethics><Future><History><Human><Immunity><Immunology><Industrialization><Inequality><Infectious Disease Pathway><Infectious Diseases><Infectious Disorder><International><Investigators><Investments><Knowledge><Learning><Licensing><Medical><Medication><Mentors><Methodology><Microbiology><Modern Man><Outcome><Pharmaceutic Preparations><Pharmaceutical Preparations><Politics><Privatization><Public Health><RNA vaccine><RNA-based vaccine><Recording of previous events><Research><Research Personnel><Researchers><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 pandemic><SARS-CoV-2 vaccine><SARS-CoV2><SARS-CoV2 epidemic><SARS-CoV2 pandemic><SARS-CoV2 vaccine><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><SARS-coronavirus-2 vaccine><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Science><Scientist><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe Acute Respiratory Syndrome CoV 2 vaccine><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Severe acute respiratory syndrome coronavirus 2 vaccine><Severe acute respiratory syndrome related corona virus 2><Smallpox><Sociology><Speed><Survey Instrument><Surveys><Systems Biology><T-Cells><T-Lymphocyte><Technology><Testing><Time><Translations><Vaccination><Vaccines><Variola><Virus><Workshop><Wuhan coronavirus><access to vaccination><access to vaccines><clinical implementation><clinical practice><combat><conference><convention><corona virus disease 2019><corona virus disease 2019 epidemic><corona virus disease 2019 pandemic><corona virus disease 2019 vaccine><coronavirus disease 2019><coronavirus disease 2019 consequence><coronavirus disease 2019 crisis><coronavirus disease 2019 effect><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 impact><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease 2019 vaccine><coronavirus disease 2019 virus><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease-19><coronavirus disease-19 global pandemic><coronavirus disease-19 impact><coronavirus disease-19 pandemic><coronavirus disease-19 vaccine><coronavirus disease-19 virus><coronavirus infectious disease-19><deploy vaccines><design><designing><developmental><distribute vaccines><drug/agent><economic><ethical><future pandemic><global health><hCoV19><histories><improved><innovate><innovation><innovative><interest><mRNA vaccine><mRNA-based vaccine><multidisciplinary><nCoV vaccine><nCoV-19 vaccine><nCoV19 vaccine><nCoV2><new drug treatments><new drugs><new pharmacological therapeutic><new technology><new therapeutics><new therapy><next generation therapeutics><next pandemic><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel technologies><novel therapeutics><novel therapy><pandemic><pandemic disease><pandemic disease preparedness><pandemic planning><pandemic preparedness><pandemic readiness><pathogen><post-COVID><post-COVID-19><post-coronavirus disease 2019><posters><prospective><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><small pox><structural biology><summit><symposia><symposium><thymus derived lymphocyte><translation><vaccination access><vaccination availability><vaccine access><vaccine against 2019-nCov><vaccine against SARS-CoV-2><vaccine against SARS-CoV2><vaccine against SARS-coronavirus-2><vaccine against Severe Acute Respiratory Syndrome CoV 2><vaccine against Severe acute respiratory syndrome coronavirus 2><vaccine availability><vaccine deployment><vaccine distribution><vaccine for novel coronavirus><vaccine platform><vaccine roll-out><vaccine rollout><vaccinology><variola major><virtual>